• Homepage
  • >
  • General News
  • >
  • Moberg Pharma Divests Its OTC-business for USD 155 Million and Secures New Funding for MOB-015 in Transformational Transaction

Moberg Pharma Divests Its OTC-business for USD 155 Million and Secures New Funding for MOB-015 in Transformational Transaction

  • by admin@News
  • 4 Days ago
  • Comments Off

STOCKHOLM, Feb. 11, 2019 /PRNewswire/ — Moberg Pharma AB (publ) (“Moberg Pharma” or the “Company”) (OMX: MOB) today announces that it has entered into agreement with a holding company owned by RoundTable Healthcare Partners and Signet Healthcare Partners (the “Purchaser”) to divest MPJ…

  • facebook
  • googleplus
  • twitter
  • linkedin
  • linkedin
Previous «
Next »